CNS Research Peptides
Semax
C₃₇H₅₁N₉O₁₀S
Key Research Findings
- Ashmarin et al. — characterisation of the modified ACTH(4-10) sequence.
- Published rodent brain-tissue BDNF transcription assay data.
- In-vitro neuronal cell-culture studies on ROS generation.
Overview
Semax is a synthetic heptapeptide analogue of the ACTH(4-10) fragment. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro and animal-model studies to modulate BDNF and NGF transcription in hippocampal cell-line assays. Not intended for human or veterinary use.
Research Effects
BDNF Transcription Studies
Extensive ResearchReported in rodent brain-tissue assays as an upregulator of BDNF transcription under controlled conditions.
NGF Pathway Activity
Moderate ResearchPublished cell-culture assays report modulation of nerve growth factor pathway activity.
Neuronal ROS Assays
Moderate ResearchIn-vitro neuronal cell studies report effects on reactive oxygen species generation in oxidative-stress assays.
Research Purposes Only — All information on this page is provided for scientific research purposes only. This product is not intended for human consumption, diagnosis, treatment, or prevention of any disease.
Quick Facts
Research Status Key
Featured in Bundles
Semax is included in the following Zenterex research peptide bundles.
Related Peptides
CNS Research Peptides
Selank
Selank is a synthetic heptapeptide analogue of the endogenous tetrapeptide tuftsin. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
CNS Research Peptides
DSIP
DSIP is a synthetic nonapeptide originally isolated from thalamic venous blood of rabbits. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Cytoprotective Peptides
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →